Breast NeoplasmsPhase 1/2NCT00127465
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
A Phase 1/2 study testing Issue of information booklet in people with Breast Neoplasms and Prostatic Neoplasms, run by University of Plymouth at 1 site in United Kingdom.
Trial summary
Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing. Design: Randomised trial with 8 groups (three factors, 2X2X2). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Breast Neoplasms, Prostatic Neoplasms, Laryngeal Neoplasms
- What is being tested?
- Issue of information booklet
- Type of treatment
- Surgery or procedure
- How many people
- 400 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Nov 2001to Jul 2003
- Phase
- Phase 1/2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients starting outpatient radiotherapy treatment with breast, prostate, cervical or laryngeal cancer
Who cannot join
- Receiving palliative care
- Severe pain or symptoms causing distress
- Having cancer at other sites
- Having no spoken English
- Receiving treatment for psychological or psychiatric problems
- Visual or mental handicap
- Having case notes not available or ambiguous or illegible.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Investigating the Impact of Tailored Reports on Anxiety
Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.
Design: Randomised trial with 8 groups (three factors, 2X2X2). Data collected at recruitment and three month follow-up.
Read more
Participants: 400 patients starting radiotherapy and their 'confidant' (the person in who they confide).
Interventions: Printed booklets.
- Half had 'general' CancerBACUP information for that cancer; half had 'personal' information from the medical record plus selected general information;
- Half chose information by 'interacting' with the computer; half had a larger volume of material in booklets that were produced 'automatically'.
- Half had additional 'anxiety management advice'.
Outcomes: Patients' views; use of booklet with others; change in reported social support; change in anxiety and depression.
Read the detailed description
Aim:
- Based on a randomised trial the researchers aimed to model use of leaflets in the home as a function of three factors:
- whether patients chose the information themselves or if it was chosen for them;
- whether it included personal information from their own medical record or not;
- whether it included anxiety management advice or not.
- The researchers aimed to model patient and confidant's anxiety at three months as a function of these three factors and patients' use of leaflets in the home.
Patient Population: Beatson Oncology Centre (BOC). Patients thought to be eligible were to be identified from outpatient appointment diaries over fifteen months. Medical records were to be checked for all those initially identified to ensure that patients have breast, gynaecological, prostate or bladder or testicular, or selected cancers of the head or neck. Patients excluded were to be those:
- receiving palliative treatment,
- with no knowledge or understanding of their diagnosis (very few),
- with visual or mental handicap,
- with severe pain or symptoms causing distress,
- medical or nursing students,
- taking part in other trials with possibly confounding interventions, and
- those not giving informed consent.
Sample size: The researchers aimed to recruit 400 patients. This was to give 80% power to find a difference between 40% and 27% who have improved anxiety between (eg) 200 in personalised group and 200 in general group.
Recruitment: Eligible patients were to be sent a letter explaining the study and advising them that a researcher will approach them in a visit to the BOC soon after, to seek participation in the study. Patients were not to be recruited at their bad news consultation but as soon as possible thereafter and at any point in their course of contact and treatment at the Beatson. At recruitment the researcher was to further explain the study and seek written consent. If the patient consented the researcher was to arrange a time for the intervention and give the patient a questionnaire to take home to complete themselves and a questionnaire for their 'confidant'.
Baseline data: Patients were to be asked to bring the completed questionnaire with them to the intervention consultation about one week later. The questionnaire included the following sections:
- previous computer and information use, perceived knowledge, significant others in providing emotional support, family and living arrangements,
- a Hospital Anxiety and Depression Scale (HADS),
- a Miller Coping Style questionnaire,
- Helgeson's measures of social support and negative interactions.
Completion of this questionnaire should have taken about half an hour at home.
Confidants: The researchers aimed to recruit 400 'confidants', one for each patient (but estimated that it were more likely to recruit (say) 60% of 400. Patients were to be asked if they were prepared to pass on the baseline questionnaire to a person selected by them as the person they are most likely to use to seek emotional support. This may be a husband, wife, partner, but may also be a daughter, son, or friend. The confidant questionnaire has sections:
- demographics and relationship to patient, newspaper read, frequency of discussion with patient, perceived knowledge
- HADS,
- Miller coping style.
The researchers did not know what proportion of patients would be prepared to pass on the questionnaire or what response rate would be received from confidants. Rees in her work with daughters of women with breast cancer found that 93% of patients passed the questionnaires on and 77% of daughters responded. If we got an overall 60% response (ie 240 before and after questionnaires) this would give us 80% power to find a difference between 40% and 23% who had improved anxiety between (eg) 120 in personalised group vs 120 in general group. The confidant population would be less than the patient population. Patients will not be excluded if there is no corresponding 'confidant'.
Randomisation for the three factors: After recruitment the RA was to randomise for each of the three binary factors (2X2X2 factorial design):
- Interactive v Automatic;
- Medical Record v General;
- Anxiety reducing advice v no advice.
Patients were to randomised to the eight sub-groups in blocks of 32 and separately by breast vs rest. The eight (2X2X2) subgroups, each receive different styles of leaflet. These are detailed further below.
Baseline Data: Collected from case notes was to be severity, length of onset of cancer, treatments so far (surgery, radiotherapy, chemotherapy), date of birth, gender, address, deprivation category from postcode for all patients, and a problem and treatment list for patients in the 'medical record' groups.
Intervention: The delay between recruitment and intervention was to allow patients time to think about their participation and withdraw if desired. At the intervention, patients were to produce a report about their cancer. Patients in the 'automatic group' would not need to use the computer.
- Interactive vs automatic. Those in the 'interactive' groups were to choose from menus, see information on the screen, and press an 'add to report' button on information screens for that information which they want to include in their report. Patients' choices were to be recorded by the computer.
- Those in the medical records group were to have personal information included based on their medical record. They were to either have information automatically selected and formatted by the computer, or to see it on screen and choose what they want to include.
- Lastly, half the patients were to have an additional section offering advice for the reduction of anxiety. This section was written based on previous work in cognitive behavioural therapy for anxiety.
All reports were to include colour photos (for example of treatment rooms, staff), and diagrams (for example, anatomical) of good quality printing etc. The patient were to be given the report to take away.
Three month follow-up: At three months patients were to be sent a follow-up questionnaire with the following sections:
- questions about their satisfaction with the information received, their use of their reports, their interactions with their family and friends, and the influence of the reports on these interactions, their perceived knowledge.
- HADS,
- Helgeson's social support questionnaires.
Significant others will be sent a questionnaire which has sections on:
- questions about their satisfaction with the information they have received,
- HADS
Measures of Outcome:
- Change in anxiety (for patient or confidant) between intervention and 3 month follow-up (HADS)
- Change in social support (for patient) between intervention and 3 months (Helgeson)
- Patient satisfaction with information score at 3 month follow-up
- Confidant satisfaction with information score at 3 month follow-up
- Whether patient had read report, shown it or discussed it with the named confidant, other family members or friends and whether the discussion was aided by use of the report.
- What patients liked and disliked about the reports.
- Amongst the interactive group, choices made between presentation styles and how well these would correspond to automatic computer choices.
- Patient and staff time, and hence costs, needed for routine delivery of each intervention will be modelled on a variety of assumptions.
Analysis: The researchers were to produce a CONSORT patient flow diagram and compare losses to follow-up by the three interventions (A,B,C). Analysis of outcomes was to be for those patients completing both intervention and follow-up. The researchers will focus on the following:
- Comparison of outcomes 1-4 by interventions A, B, and C while controlling for age, gender, cancer site, time since diagnosis, severity, coping style, using analysis of variance (factorial design) and multiple logistic regression.
- Comparison of outcomes 5 and 6 by interventions A,B, and C (qualitative).
- Modelling of anxiety (outcomes 1-2) on use of report at home (outcome 4), perceived social support, and interventions A,B,C.
- Frequencies of choices (outcome 7) and comparison with automatic selection, both statistically and through qualitative description of the differences.
- Comparison of patient and NHS costs (outcome 8) will be made between the methods used in this trial and other methods of providing information.
- Comparison of anxiety change in patient and significant other.
- Analyses will be on those completing follow-up. No substitution of data will be carried out for those randomised but not completing follow-up. The researchers will thus be able to make provisional conclusions on how the different types of information provision influence interaction, anxiety and patient satisfaction, and on the correlation between the use of information with family, and anxiety; The researchers will have information on patient selection to inform the better development of automatic systems, and costs to inform practical deployment.
- Being tested
- Issue of information booklet
- Keywords
- Medical Informatics, Patient education, Social support, Cancer, Anxiety
- Medical subject headings
- Breast Neoplasms, Prostatic Neoplasms, Laryngeal Neoplasms, Uterine Cervical Neoplasms, Neoplasms, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Issue of information bookletProcedure or surgery
What is being measured
The primary outcome is the main question the study is designed to answer.
patients' views three months after intervention
use of booklet with others between intervention and three month follow up
change in reported social support between recruitment and three month follow up
change in anxiety and depression between recruitment and three month follow up
Secondary outcomes (2)
confidants' views three months after intervention
change in confidants' anxiety and depression between recruitment and three month follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2005 (estimated)
- Study startNov 2001
- Study completionJul 2003
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Breast NeoplasmsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1/2
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Enrolment
- 400 participants
Sponsor and investigators
- Lead sponsor
- University of Plymouth
- Sponsor type
- University, hospital or other
- Investigators
- Ray Jones, PhD, Principal investigator, University of Plymouth
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00127465
- Sponsor's protocol ID
- ESRC-L328253025
- Status last verified
- Aug 2005
- First submitted
- 4 Aug 2005
- Last updated
- 11 Dec 2008
- Results posted
- No
Publications
Jones RB, Pearson J, Bental D, Cawsey A, Gilmour WH, Barrett A et al. The effect of tailored reports on the anxiety of cancer patients. Final Report to ESRC on grant number L328253024, February 2004. (Details available on the Economic and Social Research Council website www.esrcsocietytoday.ac.uk)
Jones RB, Pearson J, Cawsey AJ, Bental D, Barrett A, White J, White CA, Gilmour WH. Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial. BMJ. 2006 Apr 22;332(7547):942-8. doi: 10.1136/bmj.38807.571042.68. Epub 2006 Apr 5.
PubMed 16597660
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigating the Impact of Tailored Reports on Anxiety
- ClinicalTrials.gov ID
- NCT00127465
- Acronym / sponsor ID
- ESRC-L328253025
- Keywords
- Medical Informatics, Patient education, Social support, Cancer, Anxiety
- Phase
- Phase 1/2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 400 participants
- Lead sponsor
- University of PlymouthUniversity, hospital or other
- Study start
- Nov 2001
- Study completion
- Jul 2003
- First posted
- 5 Aug 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.
Design: Randomised trial with 8 groups (three factors, 2X2X2). Data collected at recruitment and three month follow-up.
Participants: 400 patients starting radiotherapy and their 'confidant' (the person in who they confide).
Interventions: Printed booklets.
- Half had 'general' CancerBACUP information for that cancer; half had 'personal' information from the medical record plus selected general information;
- Half chose information by 'interacting' with the computer; half had a larger volume of material in booklets that were produced 'automatically'.
- Half had additional 'anxiety management advice'.
Outcomes: Patients' views; use of booklet with others; change in reported social support; change in anxiety and depression.
Detailed description
Aim:
- Based on a randomised trial the researchers aimed to model use of leaflets in the home as a function of three factors:
- whether patients chose the information themselves or if it was chosen for them;
- whether it included personal information from their own medical record or not;
- whether it included anxiety management advice or not.
- The researchers aimed to model patient and confidant's anxiety at three months as a function of these three factors and patients' use of leaflets in the home.
Patient Population: Beatson Oncology Centre (BOC). Patients thought to be eligible were to be identified from outpatient appointment diaries over fifteen months. Medical records were to be checked for all those initially identified to ensure that patients have breast, gynaecological, prostate or bladder or testicular, or selected cancers of the head or neck. Patients excluded were to be those:
- receiving palliative treatment,
- with no knowledge or understanding of their diagnosis (very few),
- with visual or mental handicap,
- with severe pain or symptoms causing distress,
- medical or nursing students,
- taking part in other trials with possibly confounding interventions, and
- those not giving informed consent.
Sample size: The researchers aimed to recruit 400 patients. This was to give 80% power to find a difference between 40% and 27% who have improved anxiety between (eg) 200 in personalised group and 200 in general group.
Recruitment: Eligible patients were to be sent a letter explaining the study and advising them that a researcher will approach them in a visit to the BOC soon after, to seek participation in the study. Patients were not to be recruited at their bad news consultation but as soon as possible thereafter and at any point in their course of contact and treatment at the Beatson. At recruitment the researcher was to further explain the study and seek written consent. If the patient consented the researcher was to arrange a time for the intervention and give the patient a questionnaire to take home to complete themselves and a questionnaire for their 'confidant'.
Baseline data: Patients were to be asked to bring the completed questionnaire with them to the intervention consultation about one week later. The questionnaire included the following sections:
- previous computer and information use, perceived knowledge, significant others in providing emotional support, family and living arrangements,
- a Hospital Anxiety and Depression Scale (HADS),
- a Miller Coping Style questionnaire,
- Helgeson's measures of social support and negative interactions.
Completion of this questionnaire should have taken about half an hour at home.
Confidants: The researchers aimed to recruit 400 'confidants', one for each patient (but estimated that it were more likely to recruit (say) 60% of 400. Patients were to be asked if they were prepared to pass on the baseline questionnaire to a person selected by them as the person they are most likely to use to seek emotional support. This may be a husband, wife, partner, but may also be a daughter, son, or friend. The confidant questionnaire has sections:
- demographics and relationship to patient, newspaper read, frequency of discussion with patient, perceived knowledge
- HADS,
- Miller coping style.
The researchers did not know what proportion of patients would be prepared to pass on the questionnaire or what response rate would be received from confidants. Rees in her work with daughters of women with breast cancer found that 93% of patients passed the questionnaires on and 77% of daughters responded. If we got an overall 60% response (ie 240 before and after questionnaires) this would give us 80% power to find a difference between 40% and 23% who had improved anxiety between (eg) 120 in personalised group vs 120 in general group. The confidant population would be less than the patient population. Patients will not be excluded if there is no corresponding 'confidant'.
Randomisation for the three factors: After recruitment the RA was to randomise for each of the three binary factors (2X2X2 factorial design):
- Interactive v Automatic;
- Medical Record v General;
- Anxiety reducing advice v no advice.
Patients were to randomised to the eight sub-groups in blocks of 32 and separately by breast vs rest. The eight (2X2X2) subgroups, each receive different styles of leaflet. These are detailed further below.
Baseline Data: Collected from case notes was to be severity, length of onset of cancer, treatments so far (surgery, radiotherapy, chemotherapy), date of birth, gender, address, deprivation category from postcode for all patients, and a problem and treatment list for patients in the 'medical record' groups.
Intervention: The delay between recruitment and intervention was to allow patients time to think about their participation and withdraw if desired. At the intervention, patients were to produce a report about their cancer. Patients in the 'automatic group' would not need to use the computer.
- Interactive vs automatic. Those in the 'interactive' groups were to choose from menus, see information on the screen, and press an 'add to report' button on information screens for that information which they want to include in their report. Patients' choices were to be recorded by the computer.
- Those in the medical records group were to have personal information included based on their medical record. They were to either have information automatically selected and formatted by the computer, or to see it on screen and choose what they want to include.
- Lastly, half the patients were to have an additional section offering advice for the reduction of anxiety. This section was written based on previous work in cognitive behavioural therapy for anxiety.
All reports were to include colour photos (for example of treatment rooms, staff), and diagrams (for example, anatomical) of good quality printing etc. The patient were to be given the report to take away.
Three month follow-up: At three months patients were to be sent a follow-up questionnaire with the following sections:
- questions about their satisfaction with the information received, their use of their reports, their interactions with their family and friends, and the influence of the reports on these interactions, their perceived knowledge.
- HADS,
- Helgeson's social support questionnaires.
Significant others will be sent a questionnaire which has sections on:
- questions about their satisfaction with the information they have received,
- HADS
Measures of Outcome:
- Change in anxiety (for patient or confidant) between intervention and 3 month follow-up (HADS)
- Change in social support (for patient) between intervention and 3 months (Helgeson)
- Patient satisfaction with information score at 3 month follow-up
- Confidant satisfaction with information score at 3 month follow-up
- Whether patient had read report, shown it or discussed it with the named confidant, other family members or friends and whether the discussion was aided by use of the report.
- What patients liked and disliked about the reports.
- Amongst the interactive group, choices made between presentation styles and how well these would correspond to automatic computer choices.
- Patient and staff time, and hence costs, needed for routine delivery of each intervention will be modelled on a variety of assumptions.
Analysis: The researchers were to produce a CONSORT patient flow diagram and compare losses to follow-up by the three interventions (A,B,C). Analysis of outcomes was to be for those patients completing both intervention and follow-up. The researchers will focus on the following:
- Comparison of outcomes 1-4 by interventions A, B, and C while controlling for age, gender, cancer site, time since diagnosis, severity, coping style, using analysis of variance (factorial design) and multiple logistic regression.
- Comparison of outcomes 5 and 6 by interventions A,B, and C (qualitative).
- Modelling of anxiety (outcomes 1-2) on use of report at home (outcome 4), perceived social support, and interventions A,B,C.
- Frequencies of choices (outcome 7) and comparison with automatic selection, both statistically and through qualitative description of the differences.
- Comparison of patient and NHS costs (outcome 8) will be made between the methods used in this trial and other methods of providing information.
- Comparison of anxiety change in patient and significant other.
- Analyses will be on those completing follow-up. No substitution of data will be carried out for those randomised but not completing follow-up. The researchers will thus be able to make provisional conclusions on how the different types of information provision influence interaction, anxiety and patient satisfaction, and on the correlation between the use of information with family, and anxiety; The researchers will have information on patient selection to inform the better development of automatic systems, and costs to inform practical deployment.
Study design
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients starting outpatient radiotherapy treatment with breast, prostate, cervical or laryngeal cancer
Key exclusion criteria (7 listed)
- Receiving palliative care
- Severe pain or symptoms causing distress
- Having cancer at other sites
- Having no spoken English
- Receiving treatment for psychological or psychiatric problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Issue of information booklet | Procedure or surgery | – |
Primary outcome
patients' views three months after intervention
use of booklet with others between intervention and three month follow up
change in reported social support between recruitment and three month follow up
change in anxiety and depression between recruitment and three month follow up
2 secondary outcomes
confidants' views three months after intervention
change in confidants' anxiety and depression between recruitment and three month follow up
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2008.
- Results publicationJones RB, Pearson J, Bental D, Cawsey A, Gilmour WH, Barrett A et al. The effect of tailored reports on the anxiety of cancer patients. Final Report to ESRC on grant number L328253024, February 2004. (Details available on the Economic and Social Research Council website www.esrcsocietytoday.ac.uk)
- Results publication: PubMed 16597660Jones RB, Pearson J, Cawsey AJ, Bental D, Barrett A, White J, White CA, Gilmour WH. Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial. BMJ. 2006 Apr 22;332(7547):942-8. doi: 10.1136/bmj.38807.571042.68. Epub 2006 Apr 5.
- Funding body with details of protocol and final report availableLink provided by the sponsor.
Related trials for Breast Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Not yet recruitingObservational study
Comparison of Reliability, Time Cost, and Participant Comfort of Lymphedema Assessments in Upper Extremity
Lymphedema, Upper Extremity Lymphedema
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ray Jones, PhD principal investigator
University of Plymouth
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1/2 study testing Issue of information booklet in people with Breast Neoplasms and Prostatic Neoplasms, run by University of Plymouth at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Dec 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this combined phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
patients' views three months after intervention. The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00127465, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2008.